Abstract
Background
Human airway smooth muscle cells (ASMCs) may have a pro-inflammatory role through the release of inflammatory mediators. Increasing evidence indicates that human β-defensins (HBDs) are related to pathogenesis of asthma.
Objectives
To examine the plasma level of HBD-1, -2 and -3 in asthmatic patients and the expression of their mouse orthologs in the lung tissue of a mouse model of chronic severe asthma. Further to investigate the effect of HBD-3 on the release of the pro-inflammatory cytokine IL-8 and to explore the mechanisms.
Methods
The plasma levels of HBD-1, -2 and -3 from 34 healthy controls and 25 asthmatic patients were determined by ELISA. The expression of mouse β-defensins MBD-1, -3 and -14 in the lung tissue of asthmatic mice was detected by Western blot. The ASMCs were cultured with HBD-3 for 24h, and then the supernatant level of IL-8 was evaluated by ELISA and the cell viability was examined by WST-1 assay. The signaling pathway was investigated with blocking antibodies or pharmacological inhibitors.
Results
The plasma levels of HBD-1 and -3 were elevated in asthmatic patients, and the expression of MBD-14, the mouse ortholog for HBD-3, was increased in asthmatic mice. HBD-3 induced IL-8 production in a CCR6 receptor-specific manner and was dependent on multiple signaling pathways. Moreover, HBD-3 induced cell apoptosis concurrently, which was dependent on the ERK1/2 MAPK pathway. Mitochondrial ROS regulated both HBD-3-induced IL-8 production and cell apoptosis.
Conclusions & Clinical Relevance
These observations provide clear evidence of an important new mechanism for the promotion of airway inflammation and tissue remodeling with potential relevance for the treatment of asthma.
This article is protected by copyright. All rights reserved.
http://ift.tt/2pYhvpw
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου